Marshall Wace North America’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$3.18M Buy
+150,480
New +$2.79M 0.01% 619
2019
Q1
Sell
-171,731
Closed -$3.38M 1657
2018
Q4
$3.38M Sell
171,731
-16,162
-9% -$288K 0.03% 326
2018
Q3
$3.33M Sell
187,893
-921,309
-83% -$18M 0.02% 394
2018
Q2
$23.9M Sell
1,109,202
-691,130
-38% -$14.3M 0.13% 179
2018
Q1
$39.9M Buy
1,800,332
+520,143
+41% +$14.4M 0.2% 121
2017
Q4
$38.9M Buy
1,280,189
+353,150
+38% +$9.39M 0.22% 107
2017
Q3
$22.2M Sell
927,039
-303,143
-25% -$8.07M 0.14% 197
2017
Q2
$30.8M Buy
1,230,182
+458,527
+59% +$9.7M 0.22% 110
2017
Q1
$17M Buy
+771,655
New +$15.7M 0.13% 192

Other funds holding EXEL

Marshall Wace North America's EXEL Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Exelixis (EXEL) in Q3 2021: 150,480 shares worth $3.18M. The stake represents 0.01% of the portfolio and ranks #619 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in EXEL as recently as Q4 2018.

Marshall Wace North America first reported a position in EXEL in Q1 2017 and has held it in 9 quarters since. The position peaked at $39.9M in Q1 2018. 340 funds tracked by Wall St. Rank hold EXEL as of Q3 2021.

  • Marshall Wace North America held 150,480 shares of Exelixis worth $3.18M as of Q3 2021.
  • Exelixis was a new Marshall Wace North America position in Q3 2021.
  • Exelixis made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #619 holding.
  • Marshall Wace North America first reported a position in Exelixis in Q1 2017 and has held it in 9 quarters since.
  • Marshall Wace North America's Exelixis position peaked at $39.9M in Q1 2018.
  • 340 funds tracked by Wall St. Rank held Exelixis as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.